Profile data is unavailable for this security.
About the company
Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products. The Company’s segments include Pharmaceutical and Specialty Solutions (PSS) and Global Medical Products and Distribution (GMPD). The PSS segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products in the United States. The GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. It connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination. It also offers Olathe medical devices.
- Revenue in USD (TTM)220.57bn
- Net income in USD552.00m
- Incorporated1979
- Employees48.00k
- LocationCardinal Health Inc7000 Cardinal PlDUBLIN 43017United StatesUSA
- Phone+1 (614) 757-3033
- Fax+1 (614) 757-6000
- Websitehttps://www.cardinalhealth.com/en.html
Mergers & acquisitions
| Acquired company | CAH:NYQ since announced | Transaction value |
|---|---|---|
| Specialty Networks LLC | -10.28% | 1.20bn |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China Resources Pharmaceutical Group Ltd | 33.79bn | 532.18m | 4.79bn | 72.99k | 8.99 | 0.7543 | 3.17 | 0.1417 | 0.6615 | 0.6615 | 42.00 | 7.89 | 1.06 | 7.06 | 3.84 | 3,615,243.00 | 3.36 | 3.02 | 12.72 | 11.35 | 15.67 | 15.72 | 3.18 | 2.87 | 1.09 | 8.70 | 0.412 | 24.73 | 12.16 | 8.86 | 10.11 | 2.80 | 13.58 | 7.05 |
| Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd | 10.61bn | 566.87m | 6.75bn | 28.05k | 12.48 | 1.39 | -- | 0.6366 | 2.52 | 2.52 | 47.25 | 22.68 | 1.01 | 6.70 | 4.70 | 2,739,343.00 | 5.67 | 5.90 | 10.56 | 12.40 | 18.07 | 18.70 | 5.63 | 5.56 | 1.35 | -- | 0.3132 | 30.02 | 6.68 | 12.32 | 2.25 | 3.34 | 27.75 | 12.05 |
| Shanghai Pharmaceuticals Holding Co Ltd | 36.49bn | 523.71m | 8.29bn | 48.16k | 17.43 | 0.9472 | -- | 0.2271 | 1.03 | 1.03 | 71.57 | 18.92 | 1.25 | 7.10 | 3.38 | 5,485,870.00 | 2.40 | 3.53 | 6.33 | 9.34 | 11.34 | 13.21 | 1.92 | 2.66 | 1.07 | 7.55 | 0.403 | 32.89 | 12.21 | 10.35 | -32.92 | -0.5896 | 8.86 | 0.00 |
| Sinopharm Group Co Ltd | 82.37bn | 1.25bn | 8.57bn | 115.96k | 6.86 | 0.8323 | 3.19 | 0.1041 | 3.13 | 3.13 | 206.13 | 25.77 | 1.59 | 9.06 | 3.72 | 5,547,442.00 | 4.01 | 4.09 | 16.32 | 17.37 | 8.13 | 8.54 | 2.52 | 2.55 | 1.15 | 6.48 | 0.3801 | 30.02 | 8.05 | 11.61 | 6.19 | 9.18 | -7.26 | 8.10 |
| Zhangzhou Pientzhng Phrmctcl Co Ltd | 1.46bn | 414.56m | 19.37bn | 2.79k | 46.72 | 9.78 | -- | 13.23 | 4.98 | 4.98 | 17.57 | 23.76 | 0.6354 | 1.74 | 13.24 | 3,800,528.00 | 18.30 | 18.82 | 22.61 | 23.91 | 45.77 | 46.55 | 28.81 | 27.98 | 4.02 | -- | 0.0898 | 36.49 | 15.69 | 16.11 | 13.15 | 19.60 | 13.83 | 31.06 |
| Cardinal Health Inc | 220.57bn | 552.00m | 23.39bn | 48.00k | 42.56 | -- | 18.67 | 0.1061 | 2.26 | 2.26 | 885.83 | -13.38 | 4.94 | 12.58 | 19.56 | 4,595,250.00 | 1.24 | -1.13 | 5.41 | -3.08 | 3.35 | 4.00 | 0.2507 | -0.2816 | 0.5084 | 29.96 | 2.26 | -- | 13.04 | 8.43 | 127.97 | -- | 4.61 | 1.40 |
| Cencora Inc | 276.54bn | 1.85bn | 43.84bn | 42.00k | 24.05 | 40.47 | 14.76 | 0.1586 | 9.14 | 9.14 | 1,364.32 | 5.43 | 4.51 | 15.45 | 12.34 | 6,584,203.00 | 3.02 | 0.9542 | 13.51 | 3.95 | 3.40 | 3.14 | 0.6699 | 0.2178 | 0.5331 | 12.61 | 0.8105 | 76.85 | 9.89 | 9.32 | 2.74 | 10.79 | 6.38 | 5.00 |
| McKesson Corp | 308.95bn | 3.00bn | 72.54bn | 45.00k | 24.95 | -- | 19.11 | 0.2348 | 22.36 | 22.36 | 2,303.89 | -15.16 | 4.76 | 14.52 | 15.06 | 6,865,578.00 | 4.87 | 1.57 | 22.01 | 6.03 | 4.07 | 4.74 | 1.02 | 0.3764 | 0.5125 | 15.05 | 1.40 | 36.01 | 11.65 | 7.59 | -15.75 | -- | 4.28 | 9.71 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2024 | 29.51m | 12.13% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 14.11m | 5.80% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 13.78m | 5.67% |
| Geode Capital Management LLCas of 31 Mar 2024 | 5.57m | 2.29% |
| BlackRock Advisors LLCas of 31 Mar 2024 | 4.51m | 1.85% |
| Arrowstreet Capital LPas of 31 Mar 2024 | 4.14m | 1.70% |
| Fidelity Management & Research Co. LLCas of 31 Mar 2024 | 4.09m | 1.68% |
| Pacer Advisors, Inc.as of 31 Mar 2024 | 3.73m | 1.53% |
| Acadian Asset Management LLCas of 31 Mar 2024 | 3.72m | 1.53% |
| AQR Capital Management LLCas of 31 Mar 2024 | 3.59m | 1.48% |
